Rabies in Livestock and Other Domestic Animals: An Updated Review
Description
Rabies is a fatal, progressive viral encephalitis caused by Rabies lyssavirus (family Rhabdoviridae,
genus Lyssavirus) that affects all warm-blooded animals, including livestock, companion animals and
wildlife, and remains one of the oldest recognised zoonoses of veterinary and public health importance.
Although dogs remain the principal reservoir and source of over 99% of human exposures worldwide,
livestock species-particularly cattle, buffalo, goats, sheep, horses and pigs-are frequently infected through
bites from rabid dogs, wildlife (foxes, jackals, mongoose, skunks and raccoons) and, in Latin America, the
common vampire bat (Desmodus rotundus), resulting in substantial production and trade losses. This
review synthesises current knowledge on the aetiology, global and Indian epidemiology, transmission
dynamics and pathogenesis of rabies in livestock and other animals, with emphasis on species-wise clinical
presentation across the furious, dumb (paralytic) and, less commonly recognised, atypical/abortive forms.
Recent field reports (2024-2025), including a point-source rabies cluster in dairy steers in Minnesota, the
first isolation of rabies virus from a Eurasian badger in Inner Mongolia with implications for wildlife-
livestock spillover, and genetic characterisation of bovine rabies viruses in South Africa, illustrate the
continuing ecological plasticity of the virus and the risk it poses to production animals even in regions with
organised control programmes. Advances in laboratory diagnosis, notably the pan-lyssavirus LN34 real-
time RT-PCR assay, are discussed alongside the classical direct fluorescent antibody test. The review
presents a species-wise classification of clinical signs, differentiates the clinical forms, and consolidates
current World Health Organization- and World Organisation for Animal Health-aligned recommendations
on pre- and post-exposure prophylaxis in animals and in humans exposed to rabid or suspect livestock,
including updated intradermal vaccination regimens. Gaps in surveillance, under-reporting in livestock,
and the continuing need for mass dog vaccination and One Health coordination to achieve the global 'Zero
by 30' target are highlighted, along with future research directions including oral wildlife vaccination,
monoclonal antibody-based biologicals and improved point-of-care diagnostics.